These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4361772)

  • 41. Extracellular pH and herpes simplex virus multiplication.
    Roizman B
    Proc Soc Exp Biol Med; 1965; 119(4):1021-3. PubMed ID: 4284309
    [No Abstract]   [Full Text] [Related]  

  • 42. Selective inhibition of the replication of herpes simplex virus by 5-halogenated analogues of deoxycytidine.
    Schildkraut I; Cooper GM; Greer S
    Mol Pharmacol; 1975 Mar; 11(2):153-8. PubMed ID: 164617
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of p-fluorophenylalanine on the replication of herpes simplex virus.
    Dym H; Becker Y
    Isr J Med Sci; 1969; 5(5):1083-6. PubMed ID: 4313007
    [No Abstract]   [Full Text] [Related]  

  • 44. Differential susceptibility to herpes simplex viruses of hamster cell lines established after exposure to chemically inactivated herpesvirus.
    Docherty JJ; O'Neill FJ; Rapp F
    J Gen Virol; 1971 Dec; 13(3):377-84. PubMed ID: 4334298
    [No Abstract]   [Full Text] [Related]  

  • 45. Cellular transformation in vitro induced by herpes simplex virus. II. Transformation of hamster embryo cells.
    Sahnazarov N; Muţiu A; Athanasiu P; Gruia M; Cajal N; Gologan R
    Rev Roum Virol (1972); 1974; 25(4):355-60. PubMed ID: 4377316
    [No Abstract]   [Full Text] [Related]  

  • 46. Cellular transformation in vitro induced by herpes simplex virus. Note I. Transformation of rat embryo cells.
    Sahnazarov N; Muţiu A; Athanasiu P; Cajal N; Gruia M; Gologan R
    Rev Roum Virol (1972); 1974; 25(4):347-53. PubMed ID: 4377315
    [No Abstract]   [Full Text] [Related]  

  • 47. Reactivation of herpes simplex virus in nonpermissive cells: dependence on cell fusion.
    Schwartz J; Elizan TS
    Trans Am Neurol Assoc; 1973; 98():174-7. PubMed ID: 4361772
    [No Abstract]   [Full Text] [Related]  

  • 48. [Herpes simplex virus: mechanism of latency and reactivation phases].
    Boulinguez S; Rogez S
    Ann Dermatol Venereol; 1997; 124(5):409-15. PubMed ID: 9739902
    [No Abstract]   [Full Text] [Related]  

  • 49. The pathogenicity of drug-resistant variants of herpes simplex virus.
    Field HJ; Goldthorpe SE
    Res Virol; 1992; 143(2):120-4. PubMed ID: 1317602
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.